ISMRC 2023

We are thrilled to announce that Haystack Oncology will be participating in the 13^th International Symposium on Minimal Residual Cancer (ISMRC), taking place May 2 – 4 in Hamburg, Germany. 

The ISMRC is a prestigious international event that brings together researchers, healthcare professionals, and industry leaders to discuss the most recent developments on biology, technologies, and clinical applications of liquid biopsy in cancer patients, including minimal residual disease detection.  

Haystack highlights

• Nickolas Papadopoulas, Haystack’s Co-founder and Professor of Oncology and Pathology at Johns Hopkins University School of Medicine, will be giving a presentation on Tuesday, May 2 at 2:45pm entitled Clinical Applications of MRD  
• Poster presentation in partnership with SensID GMBH 
  • Title: Use of a highly sensitive minimal residual disease test to characterize novel cell-free DNA reference material
  • Poster session: Liquid biopsy-based Detection of Primary Cancer and MRD – Part II 
  • Date & time: Wednesday, May 3 from 4:30pm – 6:30pm CET
  • Poster terminal 3 

If you plan on attending, we invite you to stop by our booth to learn more about Haystack Oncology and our ultrasensitive MRD test. We look forward to connecting with other leaders in the field and learning about the latest research and innovations in minimal residual cancer. 

Nickolas Papadopoulas, Ph.D. 
Haystack Oncology Co-founder and Professor of Oncology and Pathology at Johns Hopkins University School of Medicine 

ISMRC presentation

Title: Clinical Applications of MRD 
Session 3: Liquid Biopsy-Based Detection of Primary Cancer & Minimal Residual Cancer – Part I
Date: May 2, 2023
Time: 2:45 – 3:45pm CET
Location: Hamburg, Germany